Researchers have identified antibodies that could lead to a broadly protective norovirus vaccine and new treatment options.

PEMGARDA™ (pemivibart) net product revenue of $13.8 million, representing 48% growth over Q3 2024 net product revenue of $9.3 ...

A main obstacle to an HIV cure is that viral DNA integrates into the chromosomes of memory T cells (blue), which evade ...

Bispecific antibodies targeting multiple SARS-CoV-2 sites offer enhanced neutralization against emerging variants, advancing ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...

The antibodies attach to a part of the virus that doesn't appear to mutate, potentially allowing them to work on multiple ...

VYD2311 is a novel monoclonal antibody (mAb) candidate being developed ... potential variability in neutralizing activity of product candidates tested in different assays, such as pseudovirus assays ...

Their new study identifies powerful antibodies capable of neutralizing a wide range of norovirus strains. The finding could lead to the design of broadly effective norovirus vaccine, as well as ...

In addition to prompting complete immunity, researchers found that the neutralizing antibodies persisted in the mouse models eight months after vaccination. When a different influenza strain was ...

Herpes has long been known to lie dormant in the body, waiting for the right moment to strike. But new research has revealed a shocking twist—rather than waiting passively, the virus actually wakes ...

IMNN-101 induced a persistent 2- to 4-fold increase in serum neutralizing antibody (NAb) titers from baseline through Week 4, further increasing NAb titers between Week 2 and Week 4. The immune ...